G+T and Cooley have advised Eucalyptus. Gunderson Dettmer and Osborne Clarke have advised Hims & Hers Health, Inc. K&L Gates has advised Blackbird Ventures. Australian digital...
Hims & Hers to Acquire Eucalyptus in USD1.15 Billion Transaction
Hims & Hers Acquires Canadian Digital Health Platform Livewell
Gunderson Dettmer has advised Hims & Hers. Hims & Hers (NYSE: HIMS), a leading health and wellness platform, has completed the acquisition of Livewell, a Canadian...
Hims & Hers Announces Acquisition of YourBio Health
Gunderson Dettmer has advised Hims & Hers. Hims & Hers Health, Inc. (NYSE: HIMS) has entered into a definitive agreement to acquire YourBio Health, Inc., a...
Hims & Hers’ Acquisition of 503B Outsourcing Facility MedisourceRx
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Hims & Hers Health in the transaction. Hims & Hers Health, a multi-specialty telehealth platform, announced its acquisition...
Backblaze’s IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Backblaze on the deal. White & Case advised Oppenheimer & Co. Backblaze, a provider of cloud storage and...
Theseus Pharmaceuticals’ $160 Million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...
TuSimple’s $1.35 Billion Initial Public Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised TuSimple on the deal, while Davis Polk advised the representatives of the several underwriters. TuSimple, a San...